Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Affluent Partners Holdings ( (HK:1466) ) just unveiled an update.
Baijin Life Science Holdings Limited has announced the composition of its board of directors, comprising executive, non-executive and independent non-executive directors, as well as the structure of its three key board committees. The company has confirmed the membership and leadership roles for the Audit, Remuneration and Nomination Committees, with independent non-executive director Wong Siu Keung, Joe serving as chairman of all three, underscoring the firm’s focus on board independence and corporate governance oversight, which is likely to be closely watched by shareholders and regulators alike.
The most recent analyst rating on (HK:1466) stock is a Sell with a HK$0.58 price target. To see the full list of analyst forecasts on Affluent Partners Holdings stock, see the HK:1466 Stock Forecast page.
More about Affluent Partners Holdings
Average Trading Volume: 400,003
Technical Sentiment Signal: Sell
Current Market Cap: HK$512.7M
For detailed information about 1466 stock, go to TipRanks’ Stock Analysis page.